STADA Arzneimittel AG’s €1.8 Billion delisting

Kirkland & Ellis advises Bain Capital Private Equity (Europe) LLP and Cinven Partners LLP on a public delisting tender offer for all remaining shares of STADA…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Paolo Bossi

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here